Korea's pharmaceutical pricing system

Published: 2008-12-10 07:00:00

Updated: 2008-12-10 07:00:00

The government intends not to cut the insurance price of an original drug if a generic product is not launched despite its listing in the eligible health insurance. However, any patent trial to confirm the scope of a patent right will not give any impact to the price readjustment.

In a meeting...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK